Getting diagnosed with chronic hepatitis C can feel overwhelming, especially when you start researching treatment options. If you’ve looked into common medications, you’ve almost certainly heard of Epclusa. But for many people, cost, side effects, insurance coverage or medical contraindications mean this drug isn’t the right fit. That’s why learning about 5 Alternatives for Epclusa can help you have an informed conversation with your doctor about what works best for your body and your budget.

Over 2.4 million people in the United States live with chronic hepatitis C, according to the CDC. Not every person responds the same way to antiviral medications. Some experience persistent headaches, nausea or fatigue on Epclusa, while others find their insurance won’t cover the brand name prescription even when it’s medically recommended. No one should have to choose between affording rent and clearing their hepatitis C virus. In this guide, we’ll break down each alternative, how they work, who they work best for, common side effects, and important factors you need to discuss with your care team before making a change.

1. Mavyret

Mavyret is one of the most widely prescribed alternatives to Epclusa, and for good reason. This all-oral, once-daily pill works for all six genotypes of hepatitis C, just like Epclusa. It also boasts a 98% overall cure rate for people without advanced liver disease. Most people complete their full treatment course in just 8 weeks, which is shorter than the standard 12 week course required for many Epclusa users.

This medication works by stopping the hepatitis C virus from making copies of itself inside your body. Unlike some older treatments, Mavyret does not require interferon injections. That means you avoid the severe flu-like symptoms that made older hepatitis C treatments almost unbearable for many patients.

Mavyret works best for:

• People with all 6 HCV genotypes
• Patients with compensated cirrhosis
• People who have not received prior hepatitis C treatment
• Patients with kidney disease, including those on dialysis

Common mild side effects include headache, tiredness, and mild nausea. Most people report these symptoms fade after the first two weeks of treatment. Always tell your doctor if you take blood thinners, seizure medications or birth control pills before starting Mavyret, as it can interact with several common prescription drugs.

2. Harvoni

Harvoni was one of the first direct-acting antiviral hepatitis C medications released to the public. While it is most effective for genotypes 1, 4, 5 and 6, it remains a trusted option for millions of people worldwide. Clinical data shows a 95% cure rate for eligible patients after 12 weeks of daily treatment.

One major benefit of Harvoni is its well-documented long-term safety record. Doctors have prescribed this medication for over 8 years, so researchers have more long-term data on outcomes than almost any other hepatitis C drug on the market today.

Treatment Length	Patient Group	Cure Rate
8 weeks	Treatment-naive, no cirrhosis	97%
12 weeks	Mild cirrhosis	96%
24 weeks	Prior treatment failure	94%

Harvoni is not recommended for people with genotype 2 or 3 hepatitis C. Common side effects are mild and include trouble sleeping, tiredness and mild stomach upset. Many insurance plans cover Harvoni at lower patient copays than Epclusa in most regions, making it a popular budget-friendly alternative.

3. Zepatier

Zepatier is an excellent option for people who cannot tolerate the active ingredients found in Epclusa. Approved for genotypes 1 and 4, this once-daily pill has one of the lowest reported side effect profiles of all modern hepatitis C treatments. Only 3% of people in clinical trials stopped taking Zepatier due to unwanted symptoms.

This medication works through two different antiviral compounds that target separate stages of the virus life cycle. This dual action makes it very effective even for people who have tried and failed older hepatitis C treatments in the past.

Before starting Zepatier, you will need to:

1. Complete a full blood panel to check liver function
2. Disclose all over the counter supplements you take regularly
3. Get tested for hepatitis B if you have not already
4. Inform your doctor about any history of depression

Most people finish treatment in 12 or 16 weeks. Zepatier is specifically recommended for patients with mild to moderate liver damage. It is also safe for people with common health conditions including diabetes and high blood pressure, which are very common among adults living with chronic hepatitis C.

4. Vosevi

Vosevi is designed specifically for people who did not achieve a cure with other hepatitis C medications, including people who previously took Epclusa. This salvage treatment has changed outcomes for thousands of people who thought they had no remaining options.

This three-in-one pill targets drug-resistant strains of the hepatitis C virus. Clinical trials published in the New England Journal of Medicine found a 96% cure rate for people who had at least one prior failed direct acting antiviral treatment course.

Unlike many other alternatives, Vosevi works for all six hepatitis C genotypes, even in people with advanced compensated cirrhosis. You will only need to take one pill each day, with or without food. There are no strict diet restrictions while on this medication.

• Mild side effects include headache, diarrhea, and tiredness
• Most symptoms resolve within 30 days of finishing treatment
• Not recommended for people with severe decompensated cirrhosis
• Standard treatment length is 12 weeks for all patient groups

5. Generic Sofosbuvir + Velpatasvir Combination

Generic versions of the active ingredients in Epclusa are now available in most countries around the world. These medications use exactly the same chemical formula as brand name Epclusa, but cost up to 90% less for patients paying out of pocket.

Many people worry generic medications are less effective or unsafe. This is not true. All approved generic hepatitis C treatments undergo exactly the same safety and effectiveness testing required for brand name drugs. The World Health Organization endorses these generic combinations as first line treatment for hepatitis C globally.

Medication Type	Average 12 Week Cost
Brand Name Epclusa	$74,760
Approved Generic Equivalent	$1,200 - $4,500

Always work with a licensed pharmacy and your doctor when purchasing generic hepatitis C medication. Never order untested products from unknown online sellers. Your pharmacist can help you verify that any generic medication meets international safety standards before you start treatment.

Every person living with hepatitis C deserves a treatment plan that works for their body, their life and their budget. None of these 5 alternatives for Epclusa are universally better than the others — the right choice depends on your genotype, liver health, other medical conditions and financial situation. Always bring this information to your next doctor's appointment, and ask questions until you fully understand the benefits and risks of every option presented to you.

You do not have to go through this process alone. Reach out to a hepatitis C patient advocate in your area if you need help navigating insurance coverage, finding affordable prescriptions or understanding your test results. Clearing the virus is possible for almost everyone today, and finding the right medication is the first and most important step.